ArticleFrontiers in immunology2026
HIDmap: a physiology-based map of human immune system development to support animal-free research and regulatory innovation.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From animal models to NAMs: a paradigm shift in developmental immunotoxicity testing.Archives of toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human immune system development is established through a sequence of tightly regulated processes occurring across multiple embryonic and fetal organs. Despite extensive research, our mechanistic understanding still relies largely on animal models, which often lack translational precision for human biology. This gap is particularly relevant for developmental immunotoxicity (DIT), where early-life exposure to environmental contaminants such as dioxins, PCBs, and PFAS has been associated with long-term immune dysfunction, including reduced vaccine responsiveness in children. To address this need, we created the Human Immune System Development Map (HIDmap), a curated, findability, accessibility, interoperability, and reusability (FAIR)-compliant digital resource that systematically captures prenatal immune ontogeny. The HIDmap integrates literature-derived data into a modular, three-layered structure linking anatomical niches, cell migration, and differentiation trajectories across 24 organs. Implemented in the MINERVA (Molecular Interaction NEtwoRks VisuAlization) platform, the HIDmap allows interactive exploration of developmental processes and molecular markers relevant to immune function. By embedding the HIDmap within the Adverse Outcome Pathway (AOP) framework, we constructed a putative AOP to demonstrate how the map can help to connect molecular initiating events related to environmental exposures - such as Aryl hydrocarbon receptor (AhR) activation - to downstream immunological key events and adverse outcomes. This resource offers a human-centered foundation for curating and visualizing human developmental immunobiology and may support the future development of predictive
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.